Portrait of Maki Nakazato
ucsf logo

Maki Nakazato, MD

She | Her | HersGeriatric Medicine
Osher Center for Integrative Health Mount Zion
Portrait of Maki Nakazato
Portrait of Maki Nakazato
ucsf logo

Maki Nakazato, MD

She | Her | HersGeriatric Medicine
Osher Center for Integrative Health Mount Zion

On this page

About me

Dr. Maki Nakazato provides comprehensive care to older adults. Her expertise includes palliative care, a subspecialty that focuses on improving quality of life for patients with serious illnesses. Her goal is to individualize treatments for each of her patients to align with what matters most to them.

Nakazato earned her medical degree at Sidney Kimmel Medical College. She completed a residency in family medicine at Chestnut Hill Hospital. She completed a fellowship in geriatrics at Stanford University and a fellowship in palliative care at the University of Virginia.

In her free time, Nakazato enjoys reading hard copy books, listening to music, singing, playing with her guinea pig, and watching movies and TV dramas.

Education & training

Board certification

  • Hospice & Palliative Medicine, American Board of Family Medicine
  • Geriatric Medicine, American Board of Family Medicine/Geriatric Med
  • Family Medicine, American Board of Family Medicine

Fellowship

  • Hospice & Palliative Medicine, University of Virginia GME
  • Geriatric Medicine, Stanford University School of Medicine

Residency

  • Family Medicine, Chestnut Hill Hospital Family Practice Residency

Degree

  • MD, Sidney Kimmel Medical College

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.